Ravy K. Vajravelu

Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

Konstantinos Papamichael, Karen A. Chachu, Ravy K. Vajravelu et al. · Clinical Gastroenterology and Hepatology · 2017 · 218 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y

Hong Song, Robert F. Hobbs, Ravy K. Vajravelu et al. · Cancer Research · 2009 · 148 citations · Full text

Breast Oncology, Immunology, Radiation Medicine +16

Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease

Konstantinos Papamichael, Ravy K. Vajravelu, Byron P. Vaughn et al. · Journal of Crohn s and Colitis · 2018 · 114 citations · Full text

In Vitro and Murine Efficacy and Toxicity Studies of Nebulized SCC1, a Methylated Caffeine-Silver(I) Complex, for Treatment of Pulmonary Infections

Carolyn L. Cannon, L.A. Hogue, Ravy K. Vajravelu et al. · Antimicrobial Agents and Chemotherapy · 2009 · 76 citations · Full text

Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age

Ravy K. Vajravelu, Lawrence Copelovitch, Mark T. Osterman et al. · Clinical Gastroenterology and Hepatology · 2019 · 56 citations · Full text

Inflammation, Renal Disease, Aging +8